The global lactase market size reached USD 273.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 456.9 Million by 2033, exhibiting a growth rate (CAGR) of 5.41% during 2025-2033. The market is burgeoning, fueled by the rising prevalence of lactose intolerance among the masses, continual technological advancements in enzyme production, and increased health awareness, alongside supportive government policies promoting lactose-free products and dietary supplements.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 273.2 Million |
Market Forecast in 2033
|
USD 456.9 Million |
Market Growth Rate 2025-2033 | 5.41% |
Growing prevalence of lactose intolerance and dietary shifts
The global market is significantly driven by the increasing global prevalence of lactose intolerance, a condition where individuals lack the enzyme lactase to properly digest lactose found in dairy products. This rising incidence is prompting a surge in demand for lactose-free dairy products, catering to a growing consumer base seeking dairy alternatives. Additionally, there's a noticeable dietary shift towards plant-based and vegan diets, which often incorporate lactose-free products. This trend is not limited to those with lactose intolerance but includes health-conscious consumers and those with ethical concerns about animal products. The food industry's response has been robust, with an expanding range of lactose-free or reduced-lactose options in various dairy categories, including milk, cheese, and yogurt, directly fueling the growth of the market.
Technological advancements in enzyme production
Technological advancements in the production and processing of lactase enzymes play a crucial role in market growth. Innovative methods in biotechnology have enabled more efficient, cost-effective production, making it more accessible for food and pharmaceutical applications. The development of genetically modified microorganisms for enhanced lactase production is a key example, leading to higher yield and purity levels of the enzyme. Moreover, advancements in enzyme stabilization techniques have extended the shelf life and effectiveness of these products. This progress is crucial for the dairy industry, allowing manufacturers to incorporate lactase more effectively in their production processes to create lactose-free or reduced-lactose products. These technological improvements not only increase the quality and variety of products available but also reduce production costs, making them more competitive and appealing in the market.
Supportive government policies and increased health awareness
The market is bolstered by supportive government policies and increased public health awareness. Governments and health organizations are actively promoting awareness about lactose intolerance for those affected. This awareness has led to higher consumer demand for lactose-free products and supplements. Furthermore, regulatory bodies have been instrumental in labeling standards for lactose-free products, ensuring transparency and helping consumers make informed choices. This regulatory environment encourages food manufacturers to invest in product applications, expanding the range of lactose-free products in the market. In addition, the general public's growing concern for health and wellness has made digestive health a priority, with an enhanced focus on improving gastrointestinal comfort and overall wellbeing for individuals with lactose intolerance.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on source, form and application.
Breakup by Source:
Yeast accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the source. This includes fungi, yeast, and bacteria. According to the report, yeast represented the largest segment.
Yeast-derived lactase is a major player in the market, widely utilized due to its high efficiency in lactose hydrolysis at varying pH and temperature conditions. This versatility makes it suitable for a broad range of applications, from dairy product processing to dietary supplements. It is particularly favored in the production of lactose-free milk, where it ensures complete lactose breakdown, improving digestibility and taste. Its robust nature and adaptability to different processing environments contribute to its widespread use. Additionally, ongoing research and development in yeast fermentation technologies are enhancing the yield and effectiveness, further cementing its position in the market.
Lactase derived from fungi is a key segment in the market, known for its effectiveness in breaking down lactose at acidic pH levels, making it suitable for various applications. It is commonly used in the food and beverage industry due to its high activity and stability. The growing demand for fermented dairy products is expected to further boost the demand for this segment.
Furthermore, bacterial lactase, often derived from strains like Lactobacillus, plays a significant role in the market, particularly in the production of fermented dairy products. It is known for its effectiveness in converting lactose to lactic acid, which is crucial in the fermentation process of yogurt and cheeses. Moreover, the growing consumer interest in probiotic and fermented foods is likely to increase the demand for the segment.
Breakup by Form:
Powder holds the largest share in the industry
A detailed breakup and analysis of the market based on the form have also been provided in the report. This includes powder and liquid. According to the report, powder accounted for the largest market share.
The powder form dominates the market due to its stability, ease of storage, and convenience in incorporating into various food and beverage products. The powder is extensively used in industrial applications, especially in the dairy industry, for producing lactose-free milk and other dairy products. Its fine granular form allows for uniform distribution in food products, ensuring consistent activity. The cost-effectiveness and long shelf life of the powder make it a preferred choice for manufacturers. Furthermore, advancements in encapsulation technologies have improved the product efficacy, enhancing its appeal in both food production and dietary supplements.
On the other hand, the liquid form finds its application primarily in the processing of liquid dairy products. Its solubility and ease of mixing make it an ideal choice for large-scale industrial applications, particularly in the production of lactose-free milk. The liquid form allows for precise dosing and efficient processing, ensuring consistent activity throughout the product. Moreover, the growing demand for lactose-free liquid dairy products is expected to continue driving the growth of this segment.
Breakup by Application:
Food and beverages represent the leading market segment
The report has provided a detailed breakup and analysis of the market based on the application. This includes food and beverages (milk, cheese, yogurt, and others), dietary supplements, and pharmaceuticals. According to the report, food and beverages represented the largest segment.
The food and beverages segment dominates the market, largely driven by the increasing demand for lactose-free dairy products among consumers with lactose intolerance and those adopting dairy-free diets. Manufacturers are incorporating the enzymes into dairy products like milk, cheese, and yogurt to make them digestible for a broader consumer base. This segment's growth is also fueled by the rising trend of clean label products, where consumers seek natural, additive-free food options. Innovation in processing techniques has allowed for a wider variety of lactose-free products with extended shelf life and improved taste profiles. Additionally, the growing awareness of digestive health and wellness has amplified the demand for lactose-free food and beverage options.
On the other hand, dietary supplements are becoming increasingly popular among individuals who are lactose intolerant but wish to consume dairy products. These supplements are available in various forms, such as tablets and capsules, and are taken before consuming lactose-containing foods to aid in their digestion. The convenience and effectiveness of these supplements in preventing the symptoms of lactose intolerance, such as bloating and gas, contribute to their growing market share. Moreover, the increasing availability of these supplements in pharmacies and health stores, coupled with targeted marketing strategies, is boosting their popularity among health-conscious consumers.
Furthermore, in the pharmaceutical industry, the product is used as an active ingredient in medications designed to treat symptoms of lactose intolerance. Its role in improving gastrointestinal health by aiding in the breakdown of lactose is crucial for the development of effective digestive aids. The segment is driven by the clinical need to manage digestive disorders and improve patient quality of life. Additionally, ongoing research into the potential broader product applications in pharmaceuticals is opening new avenues for market growth.
Breakup by Region:
Europe leads the market, accounting for the largest lactase market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Europe accounted for the largest market share.
Europe holds a significant position in the market, largely due to the high prevalence of lactose intolerance among its population, particularly in Northern European countries. The region boasts advanced food processing technologies and stringent food quality standards, which drive the demand for lactase in dairy product manufacturing. Additionally, the European market is characterized by a strong presence of key producers and robust R&D activities in enzyme technology. Consumer awareness about lactose intolerance and health consciousness is also higher here, leading to a steady demand for lactose-free products. Moreover, the European Union's supportive regulatory framework for food additives and enzymes further facilitates the growth and innovation in the sector.
On the other hand, the Asia Pacific market is rapidly growing, driven by increasing awareness of lactose intolerance and changing dietary preferences towards dairy products. The region also presents a significant opportunity for lactase enzyme manufacturers due to its large population base and growing health consciousness among consumers. Additionally, local governments are increasingly focusing on food safety and quality, which is expected to further boost the lactase market in this region.
North America is a key market, with a substantial demand stemming from the United States and Canada. This demand is fueled by a high prevalence of lactose intolerance among the population, along with a growing trend towards health and wellness.
In Latin America, the market is growing steadily, influenced by increasing consumer awareness of lactose intolerance and a rising preference for lactose-free dairy products. The region also shows potential for the expansion of global lactase enzyme manufacturers, looking to tap into emerging markets.
The market in the Middle East and Africa is in a nascent stage but shows potential for growth. This is attributed to a gradually increasing awareness of lactose intolerance and a growing demand for dairy alternatives in these regions. The market is also benefiting from the rising health consciousness and changing dietary habits among the population.
Key players in the market are actively expanding their reach and enhancing their product portfolios to meet the diverse and growing demands of the industry. They are investing in research and development to innovate more efficient and stable lactase enzyme formulations, catering to both food and pharmaceutical applications. Many are focusing on strategic partnerships and acquisitions to broaden their technological capabilities and market presence, especially in emerging economies. Additionally, these companies are increasingly emphasizing sustainable and eco-friendly production methods, aligning with the global shift towards environmentally responsible practices. They are also adapting to regulatory changes and consumer preferences, particularly in developing lactose-free and health-oriented products, to capture a larger share of the health-conscious consumer market.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Sources Covered | Fungi, Yeast, Bacteria |
Forms Covered | Powder, Liquid |
Applications Covered |
|
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Advanced Enzyme Technologies, Antozyme Biotech Pvt Ltd, Biolaxi Corporation, Chr. Hansen Holding A/S, Creative Enzymes, DuPont de Nemours Inc, Kerry Inc., Koninklijke DSM N.V., Merck KGaA, Novozymes A/S, Polttimo Oy, etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
We expect the global lactase market to exhibit a CAGR of 5.41% during 2025-2033.
The rising number of lactose-intolerant individuals, coupled with the increasing consumption of lactase pills to ease irritable bowel syndrome (IBS) symptoms, is primarily driving the global lactase market.
The sudden outbreak of the COVID-19 pandemic has led to the changing consumer inclination from conventional brick-and-mortar distribution channels towards online retail platforms for the purchase of lactase in different dosage forms, including drops, capsules, tablets, etc.
Based on the source, the global lactase market can be segmented into fungi, yeast, and bacteria. Currently, yeast holds the majority of the total market share.
Based on the form, the global lactase market has been divided into powder and liquid, where powder currently exhibits a clear dominance in the market.
Based on the application, the global lactase market can be categorized into food and beverages, dietary supplements, and pharmaceuticals. Among these, the food and beverage sector accounts for the largest market share.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where Europe currently dominates the global market.
Some of the major players in the global lactase market include Advanced Enzyme Technologies, Antozyme Biotech Pvt Ltd, Biolaxi Corporation, Chr. Hansen Holding A/S, Creative Enzymes, DuPont de Nemours Inc., Kerry Inc., Koninklijke DSM N.V., Merck KGaA, Novozymes A/S, and Polttimo Oy.